Astellas Pharma Ireland

Astellas employs over 400 people in Ireland across three locations. Astellas Pharma Co.,Ltd. is located in Citywest Business Campus, Dublin 24, and is responsible for the sales and marketing of products in Ireland. In addition, there are two manufacturing sites located in Killorglin, Co.Kerry and Mulhuddart, Co.Dublin.

Astellas Pharma Co.,Ltd.(APCL) is responsible for the sales and marketing of products in Ireland and is a registered member of the Irish Pharmaceutical Healthcare Association. APCL has successfully launched innovative products and established itself as a category leader in the therapeutic areas of Transplantation and Urology.

Astellas has a long standing reputation in Ireland, which has been growing following the merger of Fujisawa and Yamanouchi in 2005.

Astellas EMEA

Astellas Pharma EMEA is part of Astellas Pharma Inc. which is one of the world’s top 20 pharmaceutical companies, employing 15,000 people globally. A young and forward-thinking company, Astellas is dedicated to improving the lives of people around the world through providing innovative and reliable pharmaceutical products.

Formed in 2005 through the merger of Yamanouchi and Fujisawa, Astellas continues to remain committed to developing first-in-class and best-in-class products in key therapeutic areas by combining outstanding R&D with marketing capabilities and continuing growth in the world pharmaceutical market.


With significant ongoing investment in R&D, Astellas continues to strengthen its capabilities as a research-driven pharmaceutical company, bringing effective therapies to patients around the world and continuing to build trusted networks amongst physicians and partners.

In Europe, Astellas’ key strengths lie in the therapy areas of Transplantation, Urology and Anti-Infectives and Pain Management. In addition, Astellas is committed to developing a portfolio of treatments to fulfil unmet needs in Oncology.